Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLG
1826
Flagstar Bank National Association
FLG
$5.93B
| $4.24M | ﹤0.01% |
115,892
-170,216
| -59% | -$6.49M |
|
1827
Axcelis
ACLS
$4.03B
| $4.24M | ﹤0.01% |
56,841
+15,510
| +38% | +$919K |
|
1828
Nu Skin
NUS
$251M
| $4.22M | ﹤0.01% |
83,221
-4,761
| -5% | -$212K |
|
1829
CALL
Hilton Worldwide
HLT
$70.7B
| $4.21M | ﹤0.01% |
+27,000
| New | +$3.89M |
|
1830
Boston Beer
SAM
$1.94B
| $4.21M | ﹤0.01% |
8,336
-10,671
| -56% | -$5.33M |
|
1831
PUT
Medtronic
MDT
$111B
| $4.21M | ﹤0.01% |
40,700
+34,900
| +602% | +$4.04M |
|
1832
Seacoast Banking Corp of Florida
SBCF
$3.38B
| $4.2M | ﹤0.01% |
118,780
+48,060
| +68% | +$1.72M |
|
1833
Badger Meter
BMI
$3.97B
| $4.19M | ﹤0.01% |
39,354
-1,186
| -3% | -$125K |
|
1834
CarGurus
CARG
$3.33B
| $4.19M | ﹤0.01% |
124,564
+20,870
| +20% | +$733K |
|
1835
J&J Snack Foods
JJSF
$1.48B
| $4.19M | ﹤0.01% |
26,519
-659
| -2% | -$99.1K |
|
|
MGLN
1836
DELISTED
Magellan Health Services, Inc.
MGLN
| $4.19M | ﹤0.01% |
44,072
+2,060
| +5% | +$195K |
|
1837
Axos Financial
AX
$5.88B
| $4.18M | ﹤0.01% |
74,871
+30,264
| +68% | +$1.69M |
|
1838
Nutrien
NTR
$31.7B
| $4.17M | ﹤0.01% |
55,498
-143,813
| -72% | -$10.1M |
|
1839
Global Ship Lease
GSL
$1.59B
| $4.16M | ﹤0.01% |
+181,652
| New | +$4.14M |
|
1840
Cannae Holdings
CNNE
$655M
| $4.15M | ﹤0.01% |
118,074
+48,116
| +69% | +$1.6M |
|
1841
TG Therapeutics
TGTX
$7.07B
| $4.15M | ﹤0.01% |
218,395
+118,164
| +118% | +$3.07M |
|
1842
Artisan Partners
APAM
$2.99B
| $4.15M | ﹤0.01% |
87,053
+49,215
| +130% | +$2.36M |
|
1843
Boise Cascade
BCC
$2.92B
| $4.14M | ﹤0.01% |
58,148
-486
| -0.8% | -$31.3K |
|
|
ALEX
1844
DELISTED
Alexander & Baldwin
ALEX
| $4.14M | ﹤0.01% |
164,857
-5,588
| -3% | -$135K |
|
1845
Protagonist Therapeutics
PTGX
$8.51B
| $4.12M | ﹤0.01% |
120,597
+83,600
| +226% | +$2.64M |
|
1846
PUT
RingCentral
RNG
$4.81B
| $4.12M | ﹤0.01% |
22,000
+12,000
| +120% | +$2.66M |
|
|
SJI
1847
DELISTED
South Jersey Industries, Inc.
SJI
| $4.12M | ﹤0.01% |
157,850
-29,210
| -16% | -$694K |
|
1848
Dorman Products
DORM
$3.82B
| $4.12M | ﹤0.01% |
36,443
+13,865
| +61% | +$1.51M |
|
1849
Valvoline
VVV
$4.95B
| $4.09M | ﹤0.01% |
109,701
-94,135
| -46% | -$3.28M |
|
1850
Allegiant Air
ALGT
$2.78B
| $4.08M | ﹤0.01% |
21,815
+168
| +0.8% | +$31.2K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.